An international collaboration has identified several genetic markers associated with the SARS-CoV-2 infection and the severity of the disease. The research, published in Nature, included the involvement of the IBB.
Researchers at the UAB and the UniZar have identified a human peptide found in the brain that blocks the α-synuclein aggregates involved in Parkinson's disease and prevents their neurotoxicity. The discovery, published in Nature Communications, may help to develop new therapeutic and diagnosis strategies for Parkinson's disease and other synuclein pathologies.
